US Patent

US11592396 — Methods and systems for spatially identifying abnormal cells

Composition of Matter · Assigned to Lumicell Inc · Expires 2030-09-01 · 4y remaining

Vulnerability score 23/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects methods and systems for imaging tumor resections.

USPTO Abstract

The present invention provides compositions and methods for imaging tumor resections.

Drugs covered by this patent

pegulicianine-acetate (PEGULICIANINE ACETATE)

Patent Metadata

Patent number: US11592396
Jurisdiction: US
Classification: Composition of Matter
Expires: 2030-09-01
Drug substance claim: Yes
Drug product claim: No
Assignee: Lumicell Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.